APO Research

APO RESEARCH · REPORT

Modafinil Oral Drugs

Selected research

Industry Growth & Trends

Global Modafinil Oral Drugs Industry Growth and Trends Forecast to 2032

Market perspective

The global Modafinil Oral Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Modafinil Oral Drugs include Xiangbei Welman Pharmaceutical, Zydus, Watson Labs, Sun Pharmaceutical, Orbion Pharmaceuticals, Cephalon, Aurobindo Pharma, Apotex and Alembic Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Modafinil Oral Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Modafinil Oral Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Modafinil Oral Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Modafinil Oral Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Modafinil Oral Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Modafinil Oral Drugs Market by Company

Xiangbei Welman Pharmaceutical

Zydus

Watson Labs

Sun Pharmaceutical

Orbion Pharmaceuticals

Cephalon

Aurobindo Pharma

Apotex

Alembic Pharma

Modafinil Oral Drugs Segment by Type

Tablets

Capsules

Modafinil Oral Drugs Segment by Application

Obstructive Sleep Apnea

Shift Work Sleep Disorder

Narcolepsy

Other

Modafinil Oral Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modafinil Oral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Modafinil Oral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modafinil Oral Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Modafinil Oral Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Modafinil Oral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Capsules Table 3. Global Modafinil Oral Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Modafinil Oral Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Modafinil Oral Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Modafinil Oral Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Modafinil Oral Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Modafinil Oral Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Modafinil Oral Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Modafinil Oral Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Modafinil Oral Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Modafinil Oral Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Modafinil Oral Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Modafinil Oral Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Modafinil Oral Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Modafinil Oral Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Modafinil Oral Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Modafinil Oral Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Modafinil Oral Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Modafinil Oral Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Modafinil Oral Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Modafinil Oral Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Modafinil Oral Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Modafinil Oral Drugs Industry Trends Table 25. Modafinil Oral Drugs Industry Drivers Table 26. Modafinil Oral Drugs Industry Opportunities and Challenges Table 27. Modafinil Oral Drugs Industry Restraints Table 28. Global Modafinil Oral Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Modafinil Oral Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Modafinil Oral Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Modafinil Oral Drugs Sales Share by Company (2021-2026) Table 32. Global Modafinil Oral Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Modafinil Oral Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Modafinil Oral Drugs Major Company Production Sites and Headquarters Table 35. Global Modafinil Oral Drugs Company, Product Type & Application Table 36. Global Modafinil Oral Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Modafinil Oral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Modafinil Oral Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Modafinil Oral Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Modafinil Oral Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Modafinil Oral Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Modafinil Oral Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Modafinil Oral Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Modafinil Oral Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Modafinil Oral Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Modafinil Oral Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Modafinil Oral Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Modafinil Oral Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Modafinil Oral Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Modafinil Oral Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Modafinil Oral Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Modafinil Oral Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Modafinil Oral Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Modafinil Oral Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Modafinil Oral Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Modafinil Oral Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Modafinil Oral Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Modafinil Oral Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Modafinil Oral Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Modafinil Oral Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Modafinil Oral Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Modafinil Oral Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Modafinil Oral Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Modafinil Oral Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Modafinil Oral Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Modafinil Oral Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Modafinil Oral Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Xiangbei Welman Pharmaceutical Company Information Table 72. Xiangbei Welman Pharmaceutical Business Overview Table 73. Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Product Portfolio Table 75. Xiangbei Welman Pharmaceutical Recent Development Table 76. Zydus Company Information Table 77. Zydus Business Overview Table 78. Zydus Modafinil Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Zydus Modafinil Oral Drugs Product Portfolio Table 80. Zydus Recent Development Table 81. Watson Labs Company Information Table 82. Watson Labs Business Overview Table 83. Watson Labs Modafinil Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Watson Labs Modafinil Oral Drugs Product Portfolio Table 85. Watson Labs Recent Development Table 86. Sun Pharmaceutical Company Information Table 87. Sun Pharmaceutical Business Overview Table 88. Sun Pharmaceutical Modafinil Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sun Pharmaceutical Modafinil Oral Drugs Product Portfolio Table 90. Sun Pharmaceutical Recent Development Table 91. Orbion Pharmaceuticals Company Information Table 92. Orbion Pharmaceuticals Business Overview Table 93. Orbion Pharmaceuticals Modafinil Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Orbion Pharmaceuticals Modafinil Oral Drugs Product Portfolio Table 95. Orbion Pharmaceuticals Recent Development Table 96. Cephalon Company Information Table 97. Cephalon Business Overview Table 98. Cephalon Modafinil Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Cephalon Modafinil Oral Drugs Product Portfolio Table 100. Cephalon Recent Development Table 101. Aurobindo Pharma Company Information Table 102. Aurobindo Pharma Business Overview Table 103. Aurobindo Pharma Modafinil Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Aurobindo Pharma Modafinil Oral Drugs Product Portfolio Table 105. Aurobindo Pharma Recent Development Table 106. Apotex Company Information Table 107. Apotex Business Overview Table 108. Apotex Modafinil Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Apotex Modafinil Oral Drugs Product Portfolio Table 110. Apotex Recent Development Table 111. Alembic Pharma Company Information Table 112. Alembic Pharma Business Overview Table 113. Alembic Pharma Modafinil Oral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Alembic Pharma Modafinil Oral Drugs Product Portfolio Table 115. Alembic Pharma Recent Development Table 116. North America Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 118. North America Modafinil Oral Drugs Sales Market Share by Country (2021-2026) Table 119. North America Modafinil Oral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Modafinil Oral Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. North America Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Modafinil Oral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Modafinil Oral Drugs Market Share by Country (2021-2026) Table 124. North America Modafinil Oral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Modafinil Oral Drugs Market Share Forecast by Country (2027-2032) Table 126. Europe Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 128. Europe Modafinil Oral Drugs Sales Market Share by Country (2021-2026) Table 129. Europe Modafinil Oral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Modafinil Oral Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Modafinil Oral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Modafinil Oral Drugs Market Share by Country (2021-2026) Table 134. Europe Modafinil Oral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Modafinil Oral Drugs Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Modafinil Oral Drugs Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Modafinil Oral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Modafinil Oral Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Modafinil Oral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Modafinil Oral Drugs Market Share by Country (2021-2026) Table 144. Asia-Pacific Modafinil Oral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Modafinil Oral Drugs Market Share Forecast by Country (2027-2032) Table 146. Latin America Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 148. Latin America Modafinil Oral Drugs Sales Market Share by Country (2021-2026) Table 149. Latin America Modafinil Oral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Modafinil Oral Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Modafinil Oral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Modafinil Oral Drugs Market Share by Country (2021-2026) Table 154. Latin America Modafinil Oral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Modafinil Oral Drugs Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Modafinil Oral Drugs Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Modafinil Oral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Modafinil Oral Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Modafinil Oral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Modafinil Oral Drugs Market Share by Country (2021-2026) Table 164. Middle East and Africa Modafinil Oral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Modafinil Oral Drugs Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Modafinil Oral Drugs Distributors List Table 169. Modafinil Oral Drugs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Modafinil Oral Drugs Image Figure 2. Global Modafinil Oral Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Modafinil Oral Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Modafinil Oral Drugs Sales (2021-2032) & (K Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsules Image Figure 8. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Modafinil Oral Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Modafinil Oral Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Modafinil Oral Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Modafinil Oral Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Modafinil Oral Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Modafinil Oral Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Modafinil Oral Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Modafinil Oral Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Modafinil Oral Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Modafinil Oral Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Modafinil Oral Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Modafinil Oral Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Modafinil Oral Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Obstructive Sleep Apnea Image Figure 24. Global Obstructive Sleep Apnea Sales YoY Growth (2021-2032) & (K Units) Figure 25. Shift Work Sleep Disorder Image Figure 26. Global Shift Work Sleep Disorder Sales YoY Growth (2021-2032) & (K Units) Figure 27. Narcolepsy Image Figure 28. Global Narcolepsy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Modafinil Oral Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Modafinil Oral Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Modafinil Oral Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Modafinil Oral Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Modafinil Oral Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Modafinil Oral Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Modafinil Oral Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Modafinil Oral Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Modafinil Oral Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Modafinil Oral Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Modafinil Oral Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Modafinil Oral Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Modafinil Oral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Modafinil Oral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Modafinil Oral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Modafinil Oral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Modafinil Oral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Modafinil Oral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Modafinil Oral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Modafinil Oral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Modafinil Oral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Modafinil Oral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Modafinil Oral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Modafinil Oral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Modafinil Oral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Modafinil Oral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Modafinil Oral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Modafinil Oral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Modafinil Oral Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Modafinil Oral Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Obstructive Sleep Apnea
  • Shift Work Sleep Disorder
  • Narcolepsy
  • Other
Companies covered
  • Xiangbei Welman Pharmaceutical
  • Zydus
  • Watson Labs
  • Sun Pharmaceutical
  • Orbion Pharmaceuticals
  • Cephalon
  • Aurobindo Pharma
  • Apotex
  • Alembic Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Modafinil Oral Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Modafinil Oral Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Modafinil Oral Drugs Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Capsules
  8. 1.4 Global Modafinil Oral Drugs Market Size by Type
  9. 1.4.1 Global Modafinil Oral Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Modafinil Oral Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Modafinil Oral Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Modafinil Oral Drugs Industry Trends
  2. 2.2 Modafinil Oral Drugs Industry Drivers
  3. 2.3 Modafinil Oral Drugs Industry Opportunities and Challenges
  4. 2.4 Modafinil Oral Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Modafinil Oral Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Modafinil Oral Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Modafinil Oral Drugs Price (2021-2026)
  4. 3.4 Global Modafinil Oral Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Modafinil Oral Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Modafinil Oral Drugs Company, Product Type & Application
  7. 3.7 Global Modafinil Oral Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Modafinil Oral Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Modafinil Oral Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Modafinil Oral Drugs Tier 1, Tier 2, and Tier 3
4 Modafinil Oral Drugs Regional Status and Outlook
  1. 4.1 Global Modafinil Oral Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Modafinil Oral Drugs Historic Market Size by Region
  3. 4.2.1 Global Modafinil Oral Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Modafinil Oral Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Modafinil Oral Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Modafinil Oral Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Modafinil Oral Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Modafinil Oral Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Modafinil Oral Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Modafinil Oral Drugs by Application
  1. 5.1 Modafinil Oral Drugs Market by Application
  2. 5.1.1 Obstructive Sleep Apnea
  3. 5.1.2 Shift Work Sleep Disorder
  4. 5.1.3 Narcolepsy
  5. 5.1.4 Other
  6. 5.2 Global Modafinil Oral Drugs Market Size by Application
  7. 5.2.1 Global Modafinil Oral Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Modafinil Oral Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Modafinil Oral Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Xiangbei Welman Pharmaceutical
  2. 6.1.1 Xiangbei Welman Pharmaceutical Company Information
  3. 6.1.2 Xiangbei Welman Pharmaceutical Business Overview
  4. 6.1.3 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Product Portfolio
  6. 6.1.5 Xiangbei Welman Pharmaceutical Recent Developments
  7. 6.2 Zydus
  8. 6.2.1 Zydus Company Information
  9. 6.2.2 Zydus Business Overview
  10. 6.2.3 Zydus Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zydus Modafinil Oral Drugs Product Portfolio
  12. 6.2.5 Zydus Recent Developments
  13. 6.3 Watson Labs
  14. 6.3.1 Watson Labs Company Information
  15. 6.3.2 Watson Labs Business Overview
  16. 6.3.3 Watson Labs Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Watson Labs Modafinil Oral Drugs Product Portfolio
  18. 6.3.5 Watson Labs Recent Developments
  19. 6.4 Sun Pharmaceutical
  20. 6.4.1 Sun Pharmaceutical Company Information
  21. 6.4.2 Sun Pharmaceutical Business Overview
  22. 6.4.3 Sun Pharmaceutical Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sun Pharmaceutical Modafinil Oral Drugs Product Portfolio
  24. 6.4.5 Sun Pharmaceutical Recent Developments
  25. 6.5 Orbion Pharmaceuticals
  26. 6.5.1 Orbion Pharmaceuticals Company Information
  27. 6.5.2 Orbion Pharmaceuticals Business Overview
  28. 6.5.3 Orbion Pharmaceuticals Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Orbion Pharmaceuticals Modafinil Oral Drugs Product Portfolio
  30. 6.5.5 Orbion Pharmaceuticals Recent Developments
  31. 6.6 Cephalon
  32. 6.6.1 Cephalon Company Information
  33. 6.6.2 Cephalon Business Overview
  34. 6.6.3 Cephalon Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cephalon Modafinil Oral Drugs Product Portfolio
  36. 6.6.5 Cephalon Recent Developments
  37. 6.7 Aurobindo Pharma
  38. 6.7.1 Aurobindo Pharma Company Information
  39. 6.7.2 Aurobindo Pharma Business Overview
  40. 6.7.3 Aurobindo Pharma Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aurobindo Pharma Modafinil Oral Drugs Product Portfolio
  42. 6.7.5 Aurobindo Pharma Recent Developments
  43. 6.8 Apotex
  44. 6.8.1 Apotex Company Information
  45. 6.8.2 Apotex Business Overview
  46. 6.8.3 Apotex Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Apotex Modafinil Oral Drugs Product Portfolio
  48. 6.8.5 Apotex Recent Developments
  49. 6.9 Alembic Pharma
  50. 6.9.1 Alembic Pharma Company Information
  51. 6.9.2 Alembic Pharma Business Overview
  52. 6.9.3 Alembic Pharma Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alembic Pharma Modafinil Oral Drugs Product Portfolio
  54. 6.9.5 Alembic Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Modafinil Oral Drugs Sales by Country
  2. 7.1.1 North America Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Modafinil Oral Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Modafinil Oral Drugs Market Size by Country
  6. 7.2.1 North America Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Modafinil Oral Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Modafinil Oral Drugs Sales by Country
  2. 8.1.1 Europe Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Modafinil Oral Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Modafinil Oral Drugs Market Size by Country
  6. 8.2.1 Europe Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Modafinil Oral Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Modafinil Oral Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Modafinil Oral Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Modafinil Oral Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Modafinil Oral Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Modafinil Oral Drugs Sales by Country
  2. 10.1.1 South America Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Modafinil Oral Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Modafinil Oral Drugs Market Size by Country
  6. 10.2.1 South America Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Modafinil Oral Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Modafinil Oral Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Modafinil Oral Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Modafinil Oral Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Modafinil Oral Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Modafinil Oral Drugs Value Chain Analysis
  2. 12.1.1 Modafinil Oral Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Modafinil Oral Drugs Production Mode & Process
  7. 12.2 Modafinil Oral Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Modafinil Oral Drugs Distributors
  10. 12.2.3 Modafinil Oral Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research